MPRINT
LIVE

Serial Number

79086898

Owner

GENFIT

Attorney

Jeffrey H. Greger

Filing Date

Apr 19, 2010

Add to watchlist:

No watchlists yet
View on USPTO

MPRINT Trademark

Serial Number: 79086898 • Registration: 4008175

MPRINT is a trademark filed by GENFIT on April 19, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GENFIT (44 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

April 19, 2010

Registration Date

August 9, 2011

Published for Opposition

May 24, 2011

Cancellation Date

April 19, 2020

Goods & Services

Biological and chemical preparations and products, for medical or veterinary purposes, for detecting, separating and analysing materials within biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid, for medical, biological and veterinary purposes; medical preparations made from clinical materials and specimens for treating metabolic, cardiovascular, and neurodegenerative disorders; medical products derived from biological fluids, namely, antibodies and pharmaceutical or veterinary preparations for disease checking and testing purposes; biological products for medical diagnoses, namely, antibodies, recombinant proteins, nucleic acids and peptides for analysing biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid, for veterinary diagnosis and research purposes

Chemicals intended for industry, research and scientific use, namely, marbles, marked chemicals or chemical probes for detecting, separating and analysing macromolecular complexes, organic or inorganic compounds, biological ingredients, medicines and other substances that are biologically active in biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid, for medical, biological and veterinary purposes

Biomedical research and development services for biological, medical and veterinary products, particularly for treatment, prevention, medical diagnosis, and monitoring the clinical status and effectiveness of therapy for patients; research and development activities under contract in the fields of biotechnology, genomics, proteomics, gene expression and protein profiling, the discovery and development of medicines and the analysis of nucleic acid in the biomedical, forensics, environmental and food industries; analysis services provided by laboratories and care centres relating to testing and dosage of materials consisting of organic or inorganic compounds and biological ingredients within biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid; research and development activities under contract in the fields of medical technology, pharmaceuticals, biochemistry and genetics, scientific research services for medical purposes, namely, maintaining, testing, extracting and providing third parties with biological fluids such as blood, serum, plasma, urine, saliva, cell culture surnatant and cerebrospinal liquid and ingredients thereof, including chemical and biological products

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
May 10, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
May 10, 2021 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jan 11, 2019 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 3, 2018 INTS
INVALIDATION PROCESSED
Dec 3, 2018 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 16, 2018 INTR
CANCELLED SECTION 71
Mar 16, 2018 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Oct 27, 2016 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2016 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 21, 2013 FINO
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 28, 2013 TCCA
FINAL DISPOSITION NOTICE SENT TO IB
Mar 20, 2012 FICS
FINAL DISPOSITION PROCESSED
Mar 20, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 9, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 9, 2011 R.PR
NOTIFICATION PROCESSED BY IB
Jul 12, 2011 GPNX
PUBLISHED FOR OPPOSITION
May 24, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 4, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 4, 2011 OP2R
NOTICE OF PUBLICATION
May 4, 2011 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 18, 2011 PREV
ASSIGNED TO LIE
Apr 18, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 29, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 28, 2011 TROA
NON-FINAL ACTION MAILED
Mar 4, 2011 CNRT
NON-FINAL ACTION WRITTEN
Mar 4, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 22, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2011 TROA
REFUSAL PROCESSED BY IB
Nov 10, 2010 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 18, 2010 RFCS
REFUSAL PROCESSED BY MPU
Oct 18, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 16, 2010 RFCR
NON-FINAL ACTION WRITTEN
Oct 15, 2010 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Oct 13, 2010 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 13, 2010 RFCR
NON-FINAL ACTION WRITTEN
Oct 12, 2010 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 12, 2010 MAFR
ASSIGNED TO EXAMINER
Oct 8, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 7, 2010 REPR